Relating the data on LOH, coding sequence mutations and/or aberrant expression of Notch1, Ikzf1, Pten, Trp53 and Bcl11b for each tumour allows a comprehensive analysis of the mechanisms of oncogene activation and TSG inactivation (Fig 5). The gene discussed is PTEN; the disease is neoplasm.